{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Immunity+Disorders&page=126", "query": { "condition": "Immunity Disorders", "page": 126 }, "page_size": 10 }, "pagination": { "page": 126, "page_size": 10, "total_count": 21236, "total_pages": 2124, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Immunity+Disorders&page=127&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Immunity+Disorders&page=125&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-11T16:05:15.160Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05897099", "title": "Comprehensive HIV and Harm Prevention Via Telehealth", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Comprehensive Tele-harm Reduction", "type": "BEHAVIORAL" }, { "name": "Off-site Linkage to HIV Prevention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 350, "start_date": "2024-10-07", "completion_date": "2028-05-31", "has_results": false, "last_update_posted_date": "2026-02-17", "last_synced_at": "2026-11-11T16:05:15.160Z", "location_count": 2, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05897099" }, { "nct_id": "NCT05330598", "title": "Evaluation of the Safety and Clinical Performance of the Connected Catheter Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Urinary Retention", "Chronic" ], "interventions": [ { "name": "Connected Catheter", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Spinal Singularity", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "MALE", "summary": "22 Years and older · Male only" }, "enrollment_count": 26, "start_date": "2022-01-27", "completion_date": "2024-02-01", "has_results": false, "last_update_posted_date": "2024-02-26", "last_synced_at": "2026-11-11T16:05:15.160Z", "location_count": 5, "location_summary": "Downey, California • Inglewood, California • Murrieta, California + 2 more", "locations": [ { "city": "Downey", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Murrieta", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05330598" }, { "nct_id": "NCT02070393", "title": "Breast-Sparing Proton Therapy for Hodgkin's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Hodgkins Disease" ], "interventions": [ { "name": "Proton", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "30 Years", "sex": "FEMALE", "summary": "10 Years to 30 Years · Female only" }, "enrollment_count": 3, "start_date": "2011-09", "completion_date": "2015-02", "has_results": false, "last_update_posted_date": "2015-02-04", "last_synced_at": "2026-11-11T16:05:15.160Z", "location_count": 1, "location_summary": "Bloomington, Indiana", "locations": [ { "city": "Bloomington", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02070393" }, { "nct_id": "NCT03584516", "title": "GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Chronic Graft-versus-host Disease" ], "interventions": [ { "name": "Itacitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 155, "start_date": "2019-01-17", "completion_date": "2023-11-03", "has_results": true, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-11-11T16:05:15.160Z", "location_count": 39, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Duarte, California + 30 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03584516" }, { "nct_id": "NCT01163617", "title": "The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Adalimumab delivered in current syringe", "type": "DEVICE" }, { "name": "Adalimumab delivered in Physiolis syringe", "type": "DEVICE" }, { "name": "Adalimumab delivered in current autoinjector", "type": "DEVICE" }, { "name": "Adalimumab delivered in Physiolis autoinjector", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "AbbVie (prior sponsor, Abbott)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 85, "start_date": "2010-05", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-11-11T16:05:15.160Z", "location_count": 10, "location_summary": "Victorville, California • Tampa, Florida • Passaic, New Jersey + 7 more", "locations": [ { "city": "Victorville", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Passaic", "state": "New Jersey" }, { "city": "Duncansville", "state": "Pennsylvania" }, { "city": "Wyomissing", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01163617" }, { "nct_id": "NCT01049217", "title": "Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Neuropathy" ], "interventions": [ { "name": "pregabalin", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 377, "start_date": "2010-04", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2021-01-28", "last_synced_at": "2026-11-11T16:05:15.160Z", "location_count": 25, "location_summary": "Phoenix, Arizona • Los Angeles, California • North Hollywood, California + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01049217" }, { "nct_id": "NCT00850668", "title": "Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Food Hypersensitivity", "Hypersensitivity", "Immediate Hypersensitivity", "Peanut Hypersensitivity" ], "interventions": [ { "name": "E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Allertein Therapeutics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 15, "start_date": "2009-10", "completion_date": "2010-10", "has_results": false, "last_update_posted_date": "2013-05-27", "last_synced_at": "2026-11-11T16:05:15.160Z", "location_count": 2, "location_summary": "Baltimore, Maryland • New York, New York", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00850668" }, { "nct_id": "NCT01950650", "title": "GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 1", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "No treatment given", "type": "BEHAVIORAL" }, { "name": "survey", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1800, "start_date": "2010-03", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2017-04-27", "last_synced_at": "2026-11-11T16:05:15.160Z", "location_count": 1, "location_summary": "Princeton, New Jersey", "locations": [ { "city": "Princeton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01950650" }, { "nct_id": "NCT03314974", "title": "Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Leukemia", "Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Lymphoma", "Chronic Myelogenous Leukemia", "Plasma Cell Leukemia", "Myeloproliferative Neoplasms", "Myelofibrosis", "Myelodysplasia", "Refractory Anemia", "High Risk Anemia", "Chronic Lymphocytic Leukemia", "Small Lymphocytic Lymphoma", "Marginal Zone B-Cell Lymphoma", "Follicular Lymphoma", "Lymphoplasmacytic Lymphoma", "Mantle-Cell Lymphoma", "Prolymphocytic Leukemia", "Diffuse Large Cell Non Hodgkins Lymphoma", "Lymphoblastic Lymphoma", "Burkitt Lymphoma", "High Grade Non-Hodgkin's Lymphoma, Adult", "Multiple Myeloma", "Juvenile Myelomonocytic Leukemia", "Biphenotypic/Undifferentiated/Prolymphocytic Leukemias", "MRD Positive Leukemia", "Natural Killer Cell Malignancies", "Acquired Bone Marrow Failure Syndromes" ], "interventions": [ { "name": "HSCT with TBI Regimen", "type": "BIOLOGICAL" }, { "name": "HSCT with Non-TBI Regimen", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "60 Years", "sex": "ALL", "summary": "Up to 60 Years" }, "enrollment_count": 300, "start_date": "2018-03-30", "completion_date": "2028-06-10", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-11-11T16:05:15.160Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03314974" }, { "nct_id": "NCT05427318", "title": "Peers Plus Mobile App for Treatment in HIV", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Human Immunodeficiency Virus" ], "interventions": [ { "name": "PATH", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "San Diego State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 309, "start_date": "2021-11-01", "completion_date": "2025-07-25", "has_results": false, "last_update_posted_date": "2025-09-24", "last_synced_at": "2026-11-11T16:05:15.160Z", "location_count": 1, "location_summary": "San Ysidro, California", "locations": [ { "city": "San Ysidro", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05427318" } ] }